95 results
Page 4 of 5
6-K
EX-99.2
ehvvz
9 Oct 20
Interim Consolidated Financial Statements
12:00am
F-1/A
EX-1.1
yny4zdp3
9 Oct 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.1
mwi4 vr7sfb3t70d
16 Sep 20
Developing cannabinoid based pharmaceuticals Corporate Presentation • September 2020
7:11am
F-1
dhpgc1czezd0ci r9e
8 Sep 20
Registration statement (foreign)
5:31pm
6-K
ab7s8
3 Aug 20
Report of Foreign Private Issuer
4:05pm
6-K
EX-99.3
qitzjt
1 Jul 20
Report of Foreign Private Issuer
9:05am
6-K
EX-99.2
87sl0
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
hr1 q8tgctp65d
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
EX-4.7
53g9vinu23xwczux8hd
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
5m3ind h2ws4e
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
rvcqlru91at2e
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
d8p2c2b
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
mp1muzs znuzu4gkk7
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-4.7
2n0zff7kj4eanjwooig8
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1/A
8to08
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
8b03f5y b7q
31 Jan 20
Registration statement (foreign)
12:00am
424B5
jg532fie9jxdl
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
gfxdwan
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
utb1x7qln
3 Dec 19
Current report (foreign)
12:00am